Ad
NURO Stock Quote Trading Chart NeuroMetrix Inc.
home / stock / nuro / nuro quote
Quote | NeuroMetrix Inc. (NASDAQ:NURO)
| Last: | $3.71 |
|---|---|
| Change Percent: | -2.16% |
| Open: | $3.78 |
| Close: | $3.71 |
| High: | $3.88 |
| Low: | $3.66 |
| Volume: | 65,500 |
| Last Trade Date Time: | 12/06/2023 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
NURO Last Five Trading Days
| Last | Open | Close | High | Low | Volume | Date |
|---|---|---|---|---|---|---|
| $3.71 | $3.78 | $3.71 | $3.88 | $3.66 | 65,500 | 12-06-2023 |
| $3.7 | $3.78 | $3.7 | $3.7999 | $3.65 | 148,319 | 12-05-2023 |
| $3.74 | $3.83 | $3.74 | $3.8937 | $3.71 | 33,096 | 12-04-2023 |
| $3.82 | $3.73 | $3.82 | $3.868 | $3.73 | 45,946 | 12-01-2023 |
| $3.93 | $4.1 | $3.93 | $4.4 | $3.72 | 317,752 | 11-30-2023 |
| $4.0929 | $3.98 | $4.0929 | $4.16 | $3.82 | 81,753 | 11-29-2023 |
| $3.82 | $4.07 | $3.82 | $4.07 | $3.82 | 7,472 | 11-28-2023 |
| $3.97 | $3.98 | $3.97 | $4 | $3.831 | 7,475 | 11-27-2023 |
| $3.97 | $4.09 | $3.97 | $4.29 | $3.97 | 10,555 | 11-24-2023 |
| $4.24 | $3.8 | $4.24 | $4.35 | $3.6 | 37,391 | 11-23-2023 |
| $4.24 | $3.8 | $4.24 | $4.35 | $3.6 | 37,391 | 11-22-2023 |
| $3.7584 | $3.84 | $3.7584 | $3.92 | $3.6096 | 101,087 | 11-21-2023 |
| $0.498 | $0.4604 | $0.498 | $0.498 | $0.4556 | 157,117 | 11-20-2023 |
| $0.504 | $0.5 | $0.504 | $0.52 | $0.48 | 58,415 | 11-17-2023 |
| $0.49 | $0.4807 | $0.49 | $0.5 | $0.4699 | 72,937 | 11-16-2023 |
| $0.5 | $0.48 | $0.5 | $0.52 | $0.48 | 82,893 | 11-15-2023 |
| $0.472 | $0.4641 | $0.472 | $0.5 | $0.4605 | 46,180 | 11-14-2023 |
| $0.4882 | $0.4704 | $0.4882 | $0.4999 | $0.4606 | 85,520 | 11-13-2023 |
| $0.4975 | $0.5024 | $0.4975 | $0.51 | $0.4851 | 342,826 | 11-10-2023 |
| $0.4902 | $0.5 | $0.4902 | $0.52 | $0.4902 | 47,093 | 11-09-2023 |
News, Short Squeeze, Breakout and More Instantly...
Ad
-
WOBURN, Mass., Dec. 05, 2023 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) noted publication of results from a NIH-funded clinical trial of Quell titled "Wireless transcutaneous electric nerve stimulation (TENS) for chronic chemotherapy-induced peripheral neuropathy (CIPN): a proof-of-conc...
-
WOBURN, Mass., Nov. 20, 2023 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NASDAQ: NURO) today announced that it will effect a one-for-eight reverse split of its common stock, effective at 5:00 pm on November 21, 2023 (the “Effective Time”). The shares underlying the Co...
-
CenterPoint Energy Inc (Holding Co) (CNP) is expected to report $0.37 for Q3 2023 The Hershey Company (HSY) is expected to report $2.47 for Q3 2023 ASE Technology Holding Co. Ltd. American Depositary Shares (each representing Two) (ASX) is expected to report for Q3 2023 Reliance Steel...